Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives $50.11 Average Target Price from Analysts
Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating […]
Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating […]
